der Vaart Sandra D van Insider Trading $LH LABORATORY CORP OF AMERICA HOLDINGS
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for der Vaart Sandra D van.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of der Vaart Sandra D van. der Vaart Sandra D van is EVP, Chief Legal Officer in LABORATORY CORP OF AMERICA HOLDINGS ($LH) and SVP, Global General Counsel in LABORATORY CORP OF AMERICA HOLDINGS ($LH).
der Vaart Sandra D van in LABORATORY CORP OF AMERICA HOLDINGS
Trading Symbol: LHIndustry: SERVICES-MEDICAL LABORATORIES [8071]
Position of der Vaart Sandra D van: EVP, Chief Legal Officer, SVP, Global General Counsel
Holdings: 5,237 shares
Current Value: $680,077
Latest Transaction: Apr 01 2021
$LH Market Capitalization: $13.45B
$LH Previous Close: $129.86
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of der Vaart Sandra D van in LABORATORY CORP OF AMERICA HOLDINGS
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 01 2021 | LH | LABORATORY CORP OF ... | van der Vaart Sandra D | EVP, Chief Legal Of ... | Sell | S | 251.88 | 812 | 204,527 | 5,237 | 6 K to 5.2 K (-13.42 %) |
Mar 30 2021 | LH | LABORATORY CORP OF ... | van der Vaart Sandra D | EVP, Chief Legal Of ... | Payment of Exercise | F | 251.58 | 687 | 172,835 | 6,049 | 6.7 K to 6 K (-10.20 %) |
Mar 30 2021 | LH | LABORATORY CORP OF ... | van der Vaart Sandra D | EVP, Chief Legal Of ... | Grant | A | 0.00 | 2,310 | 0 | 6,736 | 4.4 K to 6.7 K (+52.19 %) |
Feb 17 2021 | LH | LABORATORY CORP OF ... | van der Vaart Sandra D | EVP, Chief Legal Of ... | Option Exercise | M | 0.00 | 283 | 0 | 1,594 | |
Feb 17 2021 | LH | LABORATORY CORP OF ... | van der Vaart Sandra D | EVP, Chief Legal Of ... | Option Exercise | M | 0.00 | 290 | 0 | 1,877 | |
Feb 17 2021 | LH | LABORATORY CORP OF ... | van der Vaart Sandra D | EVP, Chief Legal Of ... | Sell | S | 236.05 | 100 | 23,605 | 4,426 | 4.5 K to 4.4 K (-2.21 %) |
Feb 17 2021 | LH | LABORATORY CORP OF ... | van der Vaart Sandra D | EVP, Chief Legal Of ... | Sell | S | 235.89 | 5 | 1,179 | 4,526 | 4.5 K to 4.5 K (-0.11 %) |
Feb 17 2021 | LH | LABORATORY CORP OF ... | van der Vaart Sandra D | EVP, Chief Legal Of ... | Sell | S | 237.06 | 103 | 24,417 | 4,531 | 4.6 K to 4.5 K (-2.22 %) |
Feb 17 2021 | LH | LABORATORY CORP OF ... | van der Vaart Sandra D | EVP, Chief Legal Of ... | Payment of Exercise | F | 238.26 | 78 | 18,584 | 4,634 | 4.7 K to 4.6 K (-1.66 %) |
Feb 17 2021 | LH | LABORATORY CORP OF ... | van der Vaart Sandra D | EVP, Chief Legal Of ... | Buy | M | 0.00 | 283 | 0 | 4,712 | 4.4 K to 4.7 K (+6.39 %) |
Feb 17 2021 | LH | LABORATORY CORP OF ... | van der Vaart Sandra D | EVP, Chief Legal Of ... | Payment of Exercise | F | 238.26 | 80 | 19,061 | 4,429 | 4.5 K to 4.4 K (-1.77 %) |
Feb 17 2021 | LH | LABORATORY CORP OF ... | van der Vaart Sandra D | EVP, Chief Legal Of ... | Buy | M | 0.00 | 290 | 0 | 4,509 | 4.2 K to 4.5 K (+6.87 %) |
Feb 08 2021 | LH | LABORATORY CORP OF ... | van der Vaart Sandra D | EVP, Chief Legal Of ... | Option Exercise | M | 0.00 | 300 | 0 | 2,167 | |
Feb 08 2021 | LH | LABORATORY CORP OF ... | van der Vaart Sandra D | EVP, Chief Legal Of ... | Sell | S | 225.85 | 109 | 24,618 | 4,219 | 4.3 K to 4.2 K (-2.52 %) |
Feb 08 2021 | LH | LABORATORY CORP OF ... | van der Vaart Sandra D | EVP, Chief Legal Of ... | Payment of Exercise | F | 223.78 | 83 | 18,574 | 4,328 | 4.4 K to 4.3 K (-1.88 %) |
Feb 08 2021 | LH | LABORATORY CORP OF ... | van der Vaart Sandra D | EVP, Chief Legal Of ... | Buy | M | 0.00 | 300 | 0 | 4,411 | 4.1 K to 4.4 K (+7.30 %) |
Feb 04 2021 | LH | LABORATORY CORP OF ... | van der Vaart Sandra D | EVP, Chief Legal Of ... | Option Exercise | A | 233.39 | 2,500 | 583,475 | 2,500 | |
Feb 04 2021 | LH | LABORATORY CORP OF ... | van der Vaart Sandra D | EVP, Chief Legal Of ... | Option Exercise | A | 0.00 | 710 | 0 | 2,467 | |
Jul 07 2020 | LH | LABORATORY CORP OF ... | van der Vaart Sandra D | EVP, Chief Legal Of ... | Sell | S | 170.00 | 435 | 73,950 | 4,044 | 4.5 K to 4 K (-9.71 %) |
Jun 26 2020 | LH | LABORATORY CORP OF ... | van der Vaart Sandra D | EVP, Chief Legal Of ... | Sell | S | 160.33 | 436 | 69,904 | 4,479 | 4.9 K to 4.5 K (-8.87 %) |
Jun 26 2020 | LH | LABORATORY CORP OF ... | van der Vaart Sandra D | EVP, Chief Legal Of ... | Sell | S | 160.33 | 436 | 69,904 | 4,915 | 5.4 K to 4.9 K (-8.15 %) |
Apr 01 2020 | LH | LABORATORY CORP OF ... | van der Vaart Sandra D | EVP, Chief Legal Of ... | Payment of Exercise | F | 131.95 | 1,106 | 145,937 | 5,351 | 6.5 K to 5.4 K (-17.13 %) |
Apr 01 2020 | LH | LABORATORY CORP OF ... | van der Vaart Sandra D | EVP, Chief Legal Of ... | Grant | A | 0.00 | 3,721 | 0 | 6,457 | 2.7 K to 6.5 K (+136.00 %) |
Feb 11 2020 | LH | LABORATORY CORP OF ... | van der Vaart Sandra D | SVP, Global General ... | Option Exercise | M | 0.00 | 367 | 0 | 2,330 | |
Feb 11 2020 | LH | LABORATORY CORP OF ... | van der Vaart Sandra D | SVP, Global General ... | Sell | S | 181.99 | 133 | 24,205 | 2,529 | 2.7 K to 2.5 K (-5.00 %) |
Feb 11 2020 | LH | LABORATORY CORP OF ... | van der Vaart Sandra D | SVP, Global General ... | Payment of Exercise | F | 182.33 | 101 | 18,415 | 2,662 | 2.8 K to 2.7 K (-3.66 %) |
Feb 11 2020 | LH | LABORATORY CORP OF ... | van der Vaart Sandra D | SVP, Global General ... | Buy | M | 0.00 | 367 | 0 | 2,763 | 2.4 K to 2.8 K (+15.32 %) |
Feb 06 2020 | LH | LABORATORY CORP OF ... | van der Vaart Sandra D | SVP, Global General ... | Option Exercise | A | 182.51 | 3,600 | 657,036 | 3,600 | |
Feb 06 2020 | LH | LABORATORY CORP OF ... | van der Vaart Sandra D | SVP, Global General ... | Option Exercise | A | 0.00 | 840 | 0 | 2,637 | |
Jul 10 2019 | LH | LABORATORY CORP OF ... | van der Vaart Sandra D | SVP, Global General ... | Sell | S | 176.75 | 2,328 | 411,474 | 2,328 | 4.7 K to 2.3 K (-50.00 %) |
Apr 03 2019 | LH | LABORATORY CORP OF ... | van der Vaart Sandra D | SVP, Global General ... | Payment of Exercise | F | 154.79 | 1,782 | 275,836 | 4,656 | 6.4 K to 4.7 K (-27.68 %) |
Apr 03 2019 | LH | LABORATORY CORP OF ... | van der Vaart Sandra D | SVP, Global General ... | Grant | A | 0.00 | 5,530 | 0 | 6,438 | 908 to 6.4 K (+609.03 %) |
Page: 1